Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/21/22 16:15 | 7/19/22 | ADTX | Health | Drug | Pharmaceutical Preparations | Albanna Amro A. | VA | O | CEO | P | 20 | 20,000 | 0 | 0 | New | 0 | D | ||||||||||||||
6/2/21 17:38 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Runge Jeffrey W. | CA | D | P | 29 | 2.93 | 0 | 10 | 400 | 13 | D | |||||||||||||||
6/2/21 16:37 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Shabahang Shahrokh | CA | DO | CHIEF IN | P | 1 | 2.93 | 0 | 0 | 0 | 1,016 | I | ||||||||||||||
6/2/21 12:20 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Albanna Amro A. | CA | DO | CEO | P | 10 | 2.93 | 0 | 3 | 0 | 752 | D | ||||||||||||||
6/2/21 12:19 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Albanna Rowena | CA | O | COO | P | 10 | 2.93 | 0 | 3 | 0 | 752 | I | ||||||||||||||
5/28/21 18:49 | 5/25/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Shabahang Shahrokh | CA | DO | CHIEF IN | P.m | 1 | 2.49 | 0 | 1 | 0 | 2,031 | M | ||||||||||||||
5/27/21 13:16 | 5/26/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Farley Thomas J | CA | O | PRINCIPA | P | 7 | 2.68 | 0 | 3 | New | 3 | D | ||||||||||||||
5/25/21 20:03 | 5/25/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Pankovcin Corinne | CA | O | CFO | P | 11 | 2.56 | 0 | 4 | 4 | 114 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |